Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL718789

Cn1ccnc1COc1cc(OCCc2ccccc2)cc(-c2nc3cccnc3[nH]2)c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
GSK3B P49841 1/20 0.34
SLC16A3 O15427 1/20 0.33
SLC16A1 P53985 1/20 0.33
FFAR1 O14842 3/20 0.33
KDM4E B2RXH2 1/20 0.33
PTGES O14684 1/20 0.33
ALOX5 P09917 1/20 0.33
PPARG P37231 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL711889 0.96 HDAC3 (0.34) SLC16A3SLC16A1HDAC3HDAC4HDAC1
Trifluoroacetic Acid SCHEMBL709074 0.95 NAMPT (0.36) KDM4EMEN1KMT2ASYKNAMPT
Trifluoroacetic Acid SCHEMBL711960 0.94 LMNA (0.37) FFAR1
SCHEMBL10206669 0.93 MEN1 (0.35) PDE4APDE4BPDE4CPDE4DGSK3B
Trifluoroacetic Acid SCHEMBL713293 0.90 MEN1 (0.36) FFAR1KDM4EPPARGMEN1KMT2A
Trifluoroacetic Acid SCHEMBL712920 0.89 KDM4E (0.38) FFAR1KDM4EPPARGCHEK2
SCHEMBL10206672 0.89 MAOB (0.35) MEN1KMT2AHDAC3HDAC4HDAC1
Trifluoroacetic Acid SCHEMBL712661 0.89 CHEK2 (0.41) PDE4APDE4BPDE4CPDE4DFFAR1
Trifluoroacetic Acid SCHEMBL712600 0.88 FAAH (0.38) FFAR1ALOX5SYK
Trifluoroacetic Acid SCHEMBL711504 0.88 NOS1 (0.35) FFAR1KDM4EMEN1KMT2ACHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940837-B1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL (JP) 2012-11-07 EP disclosed
US-8124617-B2 Imidazopyridine compounds TAKEDA SAN DIEGO, INC. (US) 2012-02-28 US disclosed
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA SAN DIEGO, INC. 2010-03-18 US disclosed
EP-1940837-A2 IMIDAZOPYRIDINE COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2008-07-09 EP disclosed
WO-2007028135-A2 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS GCK, GCKR, KHK PDE4A 502/4885PDE4B 468/4885PDE4C 606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.